These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10347688)

  • 21. [Has the time come to measure the hemodynamic response to pharmaco-logical treatments of portal hypertension?].
    Morales J; Péron JM; Vinel JP
    Gastroenterol Clin Biol; 2001 Oct; 25(10):863-5. PubMed ID: 11852386
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-blockers in portal hypertension. An overview.
    Lewis JA; Davis JM; Allsopp D; Cameron HA
    Drugs; 1989; 37 Suppl 2():62-9; discussion 74-6. PubMed ID: 2572413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-adrenergic blockers for portal hypertension. Lessons from animal models.
    Sikuler E
    J Hepatol; 1991 Mar; 12(2):133-5. PubMed ID: 1675643
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
    Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
    [No Abstract]   [Full Text] [Related]  

  • 25. Improved survival with nonselective beta blockers.
    Thalheimer U; Bosch J; Patch D; Burroughs A
    Hepatology; 2008 Dec; 48(6):2091-2. PubMed ID: 19030169
    [No Abstract]   [Full Text] [Related]  

  • 26. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic therapy of portal hypertension.
    Minor MA; Grace ND
    Clin Liver Dis; 2006 Aug; 10(3):563-81, ix. PubMed ID: 17162228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment arterial hypertension by beta-adrenergic blockers in elderly patients with gastrointestinal disorders].
    Komissarenko IA
    Eksp Klin Gastroenterol; 2002; (4):18-20, 130. PubMed ID: 12503267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic venous pressure gradient: to measure or not to measure, that is the question.
    Sanyal AJ
    Hepatology; 2000 Nov; 32(5):1175-6. PubMed ID: 11050073
    [No Abstract]   [Full Text] [Related]  

  • 33. Portal hypertension. Update on pathophysiology and management.
    Chatila R
    J Med Liban; 2001; 49(2):101-5. PubMed ID: 11910964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian variation in portal pressure: appropriate use of non-selective beta blockers in the prevention of variceal bleed.
    Mann NS; Leung JW
    Med Hypotheses; 2001 Oct; 57(4):423-5. PubMed ID: 11601861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.
    Tiani C; Abraldes JG; Bosch J
    Dig Liver Dis; 2008 May; 40(5):318-27. PubMed ID: 18291732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular liver disorders (II): portal vein thrombosis.
    Hoekstra J; Janssen HL
    Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non-cardiac indications for administration of molsidomine. Conclusions/perspectives].
    May B
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():75. PubMed ID: 7968915
    [No Abstract]   [Full Text] [Related]  

  • 38. Fate of bradykinin on the rat liver when administered by the venous or arterial route.
    Gioli-Pereira L; Nascimento EA; Santos EL; Bracht A; Juliano MA; Pesquero JB; Borges DR; Kouyoumdjian M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Losartan in preascitic cirrhosis.
    Castaño G; Viudez P; Sookoian S
    Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.
    Dunne P; Young D; Chuah CS; Hayes P; Tripathi D; Leithead J; Smith L; Gaya D; Forrest E; Stanley AJ
    Aliment Pharmacol Ther; 2022 Jul; 56(1):186-187. PubMed ID: 35689317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.